Athira Pharma Inc. (ATHA) Social Stream



Athira Pharma Inc. (ATHA): $2.64

0.08 (+3.13%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ATHA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#159 of 357

in industry

ATHIRA PHARMA INC (ATHA) Price Targets From Analysts

Use the tables below to see what analysts covering ATHIRA PHARMA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-19 2 $36 $32 $34 $2.87 1084.67%
2022-04-21 3 $36 $32 $33.666 $2.87 1073.03%
2022-05-13 4 $36 $32 $33.5 $2.87 1067.25%
2022-08-16 6 $33 $3 $16 $2.87 457.49%
2022-11-11 6 $33 $3.5 $16.75 $2.87 483.62%
2023-03-24 6 $33 $3 $16.666 $2.87 480.7%
2023-04-05 5 $20 $3 $8.8 $2.87 206.62%
2023-05-11 4 $20 $3 $8.8 $2.87 206.62%
2023-08-11 4 $20 $3 $8.4 $2.87 192.68%
2023-12-17 4 $19 $1.75 $7.95 $2.87 177%

The Trend in the Analyst Price Target


Over the past 18 months, ATHA's average price target has gone down $8.05.

ATHA reports an average of 340.76% for its upside potential over the past 38 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-24 6 33 3 16.666 2.450 580.24%
2023-04-05 5 20 3 8.800 2.355 273.67%
2023-04-05 6 33 3 12.833 2.355 444.93%
2023-08-11 4 20 3 8.400 2.810 198.93%
2023-08-11 4 19 3 8.200 2.810 191.81%

ATHA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

The Trend in the Broker Recommendations


ATHA's average broker recommendation rating worsened by 1 over the prior 28 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how ATHIRA PHARMA INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1015.18% of that group.
  • To contextualize these metrics, consider that out of all US stocks, ATHIRA PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 1379.08% of them.
  • In terms of how ATHIRA PHARMA INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 342.21% of that group.
  • In the context of Healthcare stocks, ATHIRA PHARMA INC's average analyst price target is higher than 427.46% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ATHIRA PHARMA INC are VOR, ACHL, and GLUE.

Is ATHA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!